1. Home
  2. PUMP vs ABCL Comparison

PUMP vs ABCL Comparison

Compare PUMP & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProPetro Holding Corp.

PUMP

ProPetro Holding Corp.

HOLD

Current Price

$10.97

Market Cap

1.1B

Sector

Energy

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.68

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PUMP
ABCL
Founded
2007
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
PUMP
ABCL
Price
$10.97
$3.68
Analyst Decision
Hold
Buy
Analyst Count
8
5
Target Price
$9.57
$7.75
AVG Volume (30 Days)
2.5M
4.0M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,300,037,000.00
$35,325,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
$1.59
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.17
52 Week Low
$4.51
$1.89
52 Week High
$11.66
$6.52

Technical Indicators

Market Signals
Indicator
PUMP
ABCL
Relative Strength Index (RSI) 66.62 42.06
Support Level $10.57 $3.42
Resistance Level $11.27 $3.73
Average True Range (ATR) 0.55 0.20
MACD 0.02 0.07
Stochastic Oscillator 86.82 75.00

Price Performance

Historical Comparison
PUMP
ABCL

About PUMP ProPetro Holding Corp.

ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: